AIX and BGM Group Forge Strategic Partnership to Revolutionize AI-Driven Healthcare and Insurance

Strategic Partnership Formed

AIX Inc. (NASDAQ:AIFU) and BGM Group Ltd. (NASDAQ:BGM) have announced a groundbreaking strategic partnership that promises to reshape the landscape of AI-driven healthcare and insurance services 1

1

2

2

. The deal, valued at approximately $140 million, involves AIX transferring its intelligent platform, consisting of RONS Intelligent Technology and Shenzhen Xinbao Investment Management, to BGM in exchange for a 72% equity stake in BGM 1

1

3

3

.

AI Integration in Healthcare and Insurance

This collaboration aims to leverage AIX's expertise in AI and insurtech with BGM's strong presence in the pharmaceutical industry. The partnership is expected to create synergies that will drive innovation in both sectors:

1. AIX's Duxiaobao AI insurance platform will be integrated into BGM's operations, potentially revolutionizing insurance services with AI-driven solutions 2

   2

   .
2. BGM's extensive resources in healthcare will provide new application scenarios for AIX's intelligent technologies, expanding their reach beyond the insurance sector 1

   1

   .

Market Implications and Growth Potential

The strategic move is anticipated to have significant market implications:

1. BGM's current market value of $52 million is expected to increase substantially as the AI insurance business expands 2

   2

   .
2. AIX, despite its $3.5 billion revenue and 237% year-on-year net profit growth, is currently undervalued with a P/E ratio of only 3.5 2

   2

   .
3. The partnership positions both companies to capitalize on the growing demand for AI-driven solutions in healthcare and insurance, particularly in light of global aging populations 2

   2

   4

   4

   .

Technological Advancements

The deal brings together cutting-edge technologies from both companies:

1. RONS Technology's RONS Open Platform and Du Xiaobao product have been disruptive in the insurtech landscape 3

   3

   .
2. Xinbao Investment's "Baowang" platform offers over 300 insurance products from more than 30 companies 3

   3

   .
3. The integration of these technologies with BGM's pharmaceutical expertise is expected to create comprehensive and intelligent healthcare and insurance solutions 4

   4

   .

Future Outlook

Both companies' leadership express optimism about the partnership's potential:

1. Mr. Yinan Hu, CEO of AIX, believes this collaboration will unlock immense opportunities and deliver greater long-term value to clients, partners, and shareholders 1

   1

   .
2. Mr. Chen Xin, CEO of BGM, sees the partnership as a way to strengthen BGM's technological competitiveness and accelerate its strategic positioning in the global market 1

   1

   4

   4

   .

As the transaction is set to close by the end of 2024, industry observers will be watching closely to see how this fusion of AI, healthcare, and insurance unfolds, potentially setting new standards for innovation and service delivery in these sectors 1

1

2

2

3

3

4

4

.